| abstract |
The present invention relates to the condensed pyrroledicarboxamides of the formula (I), wherein R1 to R9, X, m and n are as defined in the claims. The compounds of the formula (I) are inhibitors of the acid-sensitive TASK-1 potassium channel and suitable for the treatment of disorders mediated by the TASXK-1 channel, in particular atrial arrhythmic activity such as atrial fibrillation or airflow atrial, and respiratory disorders, particularly sleep-related respiratory disorders, such as sleep apnea. |